Shimadzu

Cannabis Testing Global Market Analysis Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 17, 2022

The "Cannabis Testing Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cannabis Testing Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The cannabis testing market research report is one of a series of new reports that provides cannabis testing market statistics, including global market size, regional shares, competitors with a cannabis testing market share, detailed cannabis testing market segments, market trends and opportunities, and any further data you may need to thrive in the cannabis testing industry.
  • For instance, in November 2020, Shimadzu Scientific Instruments, a Japan-based manufacturer of cannabis testing instruments, partnered with McCann Testing, a US-based medical cannabis testing lab.
  • Doane University Cannabis Testing Laboratories (CTL) is a US-based wholly-owned subsidiary of parent firm Doane University that has established itself as Nebraska's first cannabis testing lab which provides cannabis testing.

JAIMA and China's Instrument Information Network to Jointly Host "Japan-China Scientists Forum - Life Sciences"

Retrieved on: 
Thursday, July 14, 2022

The Japan Analytical Instruments Manufacturers' Association (hereinafter "JAIMA"; location: 2-5-16 Kanda Nishiki-cho, Chiyoda-ku, Tokyo, 101-0054 Japan; president: Akira Nakamoto; senior corporate advisor: Shimadzu Corporation) announces that, on Wednesday July 20, 2022, it will jointly hold the second online "Japan-China Scientists Forum - Life Sciences" with China's Instrument Information Network.

Key Points: 
  • The Japan Analytical Instruments Manufacturers' Association (hereinafter "JAIMA"; location: 2-5-16 Kanda Nishiki-cho, Chiyoda-ku, Tokyo, 101-0054 Japan; president: Akira Nakamoto; senior corporate advisor: Shimadzu Corporation) announces that, on Wednesday July 20, 2022, it will jointly hold the second online "Japan-China Scientists Forum - Life Sciences" with China's Instrument Information Network.
  • This year's theme is "life sciences," and JAIMA has invited Professor Emeritus Toshihiro Akaike of the Tokyo Institute of Technology as the keynote speaker.
  • Professor Akaike started his career in polymer chemistry at the University of Tokyo and continued his research into biomaterials connecting polymer chemistry and bio-chemistry through his work at Tokyo Women's Medical University.
  • This year's lectures will cover the latest in biomaterials, from regenerative medicine and drug delivery to vaccines based on cadherin biology and cadherin engineering.

Shimadzu Medical Systems USA releases the MobileDaRt Evolution MX8 V type, the next evolution of the MobileDaRt Evolution series

Retrieved on: 
Monday, July 11, 2022

TORRANCE, Calif., July 11, 2022 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the release of the MobileDaRt Evolution MX8 Version V type.

Key Points: 
  • TORRANCE, Calif., July 11, 2022 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the release of the MobileDaRt Evolution MX8 Version V type.
  • Shimadzu mobile X-ray systems are equipped with GLIDE Technologies, a proprietary motorized assist that enables smooth, nimble operation with tight turns.
  • Since 2020, the need for mobile X-ray systems has expanded globally in order to diagnose pneumonia resulting from COVID-19 infections.
  • Shimadzu Corporation, founded in 1875 in Kyoto, Japan and the parent of Shimadzu Medical Systems USA (SMS), is a global provider of medical diagnostic equipment including conventional, interventional and digital X-Ray systems.

Shimadzu Launches Blood-Based Amyloid Mass Spectrometry Service in North America for Supporting Alzheimer's Disease Drug Discovery and Development

Retrieved on: 
Friday, July 8, 2022

COLUMBIA, Md., July 8, 2022 /PRNewswire-PRWeb/ -- Shimadzu Scientific Instruments announces the successful commercialization of a new Amyloid Mass Spectrometry (MS) Service for the early screening of amyloid-positive individuals. This simple, research-use-only blood-based analysis method enables reliable characterization of amyloid pathology in the brain with an easy-to-acquire blood sample to assist in the evaluation and development of new pharmaceutical treatments for Alzheimer's disease.

Key Points: 
  • Shimadzu Scientific Instruments announces the successful commercialization of a new Amyloid Mass Spectrometry (MS) Service for the early screening of amyloid-positive individuals.
  • COLUMBIA, Md., July 8, 2022 /PRNewswire-PRWeb/ -- Shimadzu Scientific Instruments announces the successful commercialization of a new Amyloid Mass Spectrometry (MS) Service for the early screening of amyloid-positive individuals.
  • Experts from Shimadzu will present information about the Amyloid Mass Spectrometry (MS) Service at booth 206 at the Alzheimer's Association International Conference from July 31August 4, 2022, in San Diego, California.
  • About Shimadzu Scientific Instruments Inc.
    Shimadzu Scientific Instruments (SSI) is the North American subsidiary of Shimadzu Corporation's Analytical and Measuring Division.

Shimadzu Scientific Instruments Extends HQ Campus With Building Acquisition

Retrieved on: 
Tuesday, June 28, 2022

COLUMBIA, Md., June 28, 2022 /PRNewswire-PRWeb/ -- Shimadzu Scientific Instruments (SSI) is pleased to announce the next phase in its planned expansion with the procurement of additional facilities at its headquarters in Columbia, Maryland. The purchase of a new two-story building has been finalized, bringing the campus to a total of three separate properties.

Key Points: 
  • The purchase of a new two-story building has been finalized, bringing the campus to a total of three separate properties.
  • The purchase of a new two-story building has been finalized, bringing the campus to a total of three separate properties.
  • SSI is a leader in the scientific instrumentation space, working with companies in pharmaceuticals, life sciences, energy, forensics and more.
  • About Shimadzu Scientific Instruments Inc.
    Shimadzu Scientific Instruments (SSI) is the North American subsidiary of Shimadzu Corporation's Analytical and Measuring Division.

With Market Size Valued at $1.5 Billion by 2026, it's a Healthy Outlook for the Global Moisture Analyzers Market

Retrieved on: 
Tuesday, June 28, 2022

SAN FRANCISCO, June 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Moisture Analyzers - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, June 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Moisture Analyzers - Global Market Trajectory & Analytics" .
  • Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more.
  • Preview Registry
    Amid the COVID-19 crisis, the global market for Moisture Analyzers estimated at US$1.2 Billion, is projected to reach a revised size of US$1.5 Billion by 2026, growing at a CAGR of 3.1% over the analysis period.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world's only influencer driven market research company.

Global Industry Analysts Predicts the World Optical Emission Spectroscopy (OES) Market to Reach $804.2 Million by 2026

Retrieved on: 
Monday, June 27, 2022

SAN FRANCISCO, June 27, 2022 /PRNewswire/ --A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Optical Emission Spectroscopy (OES) - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, June 27, 2022 /PRNewswire/ --A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Optical Emission Spectroscopy (OES) - Global Market Trajectory & Analytics" .
  • Preview Registry
    Amid the COVID-19 crisis, the global market for Optical Emission Spectroscopy (OES) estimated at US$594.7 Million, is projected to reach a revised size of US$804.2 Million by 2026, growing at a CAGR of 5% over the analysis period.
  • The U.S. Market is Estimated at $187.3 Million in 2021, While China is Forecast to Reach $142.5 Million by 2026
    The Optical Emission Spectroscopy (OES) market in the U.S. is estimated at US$187.3 Million in the year 2021.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

New Nexera™ XS inert UHPLC System Eliminates Challenges of High-Concentration Mobile Phases to Achieve High Sensitivity and Reliability

Retrieved on: 
Thursday, June 23, 2022

COLUMBIA, Md., June 23, 2022 /PRNewswire-PRWeb/ -- Shimadzu Scientific Instruments introduces the Nexera™ XS inert ultra high performance liquid chromatograph (UHPLC), which eliminates the risk of adsorption or corrosion by high-concentration mobile phases. Providing the same expandability and superior performance advantages of the Nexera series of modular UHPLC/HPLC systems, the Nexera XS inert system provides a solution for challenges with adsorption that compromise quantitative accuracy, sensitivity or separation and mobile phases that cause system durability problems.

Key Points: 
  • Shimadzu Scientific Instruments introduces the Nexera XS inert ultra high performance liquid chromatograph (UHPLC), which eliminates the risk of adsorption or corrosion by high-concentration mobile phases.
  • COLUMBIA, Md., June 23, 2022 /PRNewswire-PRWeb/ -- Shimadzu Scientific Instruments introduces the Nexera XS inert ultra high performance liquid chromatograph (UHPLC), which eliminates the risk of adsorption or corrosion by high-concentration mobile phases.
  • Providing the same expandability and superior performance advantages of the Nexera series of modular UHPLC/HPLC systems, the Nexera XS inert system provides a solution for challenges with adsorption that compromise quantitative accuracy, sensitivity or separation and mobile phases that cause system durability problems.
  • Using unique proprietary technology, the Nexera XS inert system minimizes exposure to metal ions at all surfaces in contact with mobile phases or sample solutions.

Worldwide Protein Detection & Quantification Industry to 2027 - Featuring General Electric, PerkinElmer and Shimadzu Among Others

Retrieved on: 
Monday, June 20, 2022

The global protein detection & quantification market reached a value of US$ 2.25 Billion in 2021.

Key Points: 
  • The global protein detection & quantification market reached a value of US$ 2.25 Billion in 2021.
  • Protein detection and quantification refer to methods that are generally adopted by scientific experts in order to determine the total protein content and its characteristics.
  • Protein Detection & Quantification Market Trends:
    The global market is primarily driven by significant growth in the pharmaceutical industry.
  • What is the structure of the global protein detection & quantification market and who are the key players?

Shimadzu Medical Systems announces Release of New Angiography System at the SIR 2022

Retrieved on: 
Sunday, June 12, 2022

TORRANCE, Calif., June 12, 2022 /PRNewswire/ -- Shimadzu Corporation will commence worldwide sales of its flagship newest version of its Trinias angiography system.

Key Points: 
  • TORRANCE, Calif., June 12, 2022 /PRNewswire/ -- Shimadzu Corporation will commence worldwide sales of its flagship newest version of its Trinias angiography system.
  • Shimadzu Medical Systems USA will introduce our innovative new technology solutions in angiography at the SIR 2022 conference, starting on Sunday, June 12, 2022.
  • The new Trinias system uses AI deep learning technology to improve the visibility of medical devices while using 40% or more lower*2 X-ray dose than previous models.
  • This represents the first time AI has been incorporated into the image processing engine of an angiography system.